Covidien plc (COV) Cash Flow Statement

Click line-items for a historical chart and %

Net income	511M
Loss (income) from discontinued operations, net of income taxes
Income from continuing operations
Depreciation and amortization	150M
Share-based compensation	24M
Deferred income taxes
Provision for losses on accounts receivable and inventory	14M
Change in receivable from former parent and affiliate related to Tax Sharing Agreement
Other non-cash items	-33M
Accounts receivable, net	15M
Inventories	-56M
Accounts payable	-19M
Income taxes	-14M
Accrued and other liabilities	-287M
Other	122M
Net cash provided by continuing operating activities
Capital expenditures	-60M
Sale of investments
Acquisition-related payments, net of cash acquired	0
Acquisition of licenses and technology
Interest in class action settlement fund
Divestitures
Other	-2M
Net cash used in continuing investing activities
Net repayment of commercial paper
Repayment of debt
Dividends paid	-163M
Repurchase of shares	-25M
Proceeds from exercise of share options	44M
Payment of contingent consideration
Other	35M
Net cash used in continuing financing activities
Net cash provided by discontinued operating activities
Net cash used in discontinued investing activities
Net cash provided by discontinued operations
Effect of currency rate changes on cash	-29M
Net increase in cash and cash equivalents	251M
Cash and cash equivalents at beginning of period	1.57B
Cash and cash equivalents at end of period	1.82B

Entities mentioned with COV

View All Entities